Bayer MEDRAD Stellant Manual De Funcionamiento página 41

Ocultar thumbs Ver también para MEDRAD Stellant:
Tabla de contenido
4. Brink J et al. Hepatic Spiral CT: Reduction of Dose of Intravenous Contrast Material.
Radiology 1995; 197:83-88.
5. Dorio et al. Using a Saline Chaser to Decrease Contrast Media in Abdominal CT. AJR 2003;
180:929–934.
6. Heiken, J et al. Dynamic Incremental CT: Effect of Volume and Concentration of Contrast
Material and Patient Weight on Hepatic Enhancement. Radiology 1995; 195:353–357.
7. Ichikawa et al. Multiphasic contrast-enhanced mutidetector-row CT of the liver: Contrast
enhancement theory and practical scan protocol with a combination of fixed injection
duration and patients' body-weight tailored dose of contrast material. EJR 2006;
58:165–176.
8. Megibow et al. Quantitative and Qualitative Evaluation of Low Osmolality Contrast Medium
needed for Routine Helical Abdominal CT. AJR 2001; 176:583–589.
9. Murakami, T et al. Determining the Optimal Timing for Early Arterial Phase Hepatic
CT Imaging by Measuring Abdominal Aortic Enhancement in Variable Contrast Injection
Protocols. JCAT 2006; 30:206–211.
10. Schoellnast H et al. Improvement of parenchymal and vascular enhancement using saline
flush and power injection for multiple-detector-row abdominal CT. EJR 2004; 14:659-664.
11. Yamashita, Y et al. Abdominal Helical CT: Evaluation of Optimal Doses of Intravenous
Contrast Material – A Prospective Randomized Study. Radiology 2000; 216:718–723.
12. Yanaga, Y et al. Patient Body Weight-tailored Contrast Material Injection Protocol versus
Fixed Dose Protocol at Dynamic CT. Radiology 2007; 245:475–487.
Anexo A
8 - 35
Tabla de contenido
loading

Tabla de contenido